• Trends in Biosimilars

    Clinical Research News | The global biosimilars market is experiencing substantial growth, valued at $29.45 billion in 2023, it is projected to reach $150.3 billion by 2033 (CAGR of 17.7%). This upward trajectory is primarily driven by the ability of biosimilars to offer safe, clinically effective, and cost-effective alternatives to reference biologics, expanding patient access to treatments for the ever-rising number of chronic and severe illnesses.

    Nov 22, 2024

  • AI Drug Repurposing Tool Offers Suggestions Based on Disease Networks

    Clinical Research News | arvard scientists, led by Dr. Marinka Zitnik, have developed an AI-based tool, TxGNN, to identify drug repurposing opportunities for diseases lacking effective treatments. The AI model harnesses a novel approach by focusing on multiple diseases simultaneously, allowing insights from well-documented conditions to be applied to rare diseases with sparse data.

    Nov 20, 2024

  • Pharma Leaders Tackle Persistent Quality Challenges and the Future of Clinical Trials

    Clinical Research News | Pharma leaders took on clinical trial quality in a panel discussion at the SCOPE Europe conference last month in Barcelona. While technologies change, the conversation underscored a central truth: the push for quality in clinical research remains as vital, yet as challenging, as ever.

    Nov 19, 2024

  • The Case for Integrating Placental Pathology into Prospective Clinical Trials

    Clinical Research News | Perinatal pathologists are calling for placental pathology to be incorporated into prospective clinical trials so they can start telling clinical providers what the findings in their reports mean. For want of funding and the relevant diagnostic expertise, the placenta has long been a woefully under-investigated organ that could be providing critical insights on pregnancy-related conditions like preeclampsia and preterm birth that are currently defined solely based on a clinical diagnosis.

    Nov 14, 2024

  • AI Regulation Sparks Debate at Scope Europe Conference: Industry Leaders Weigh In

    Clinical Research News | Last week at SCOPE Europe, industry leaders took on the impact of AI regulation—particularly the European Union's AI Act—on the clinical research and life sciences sectors. Moderated by BioSpace’s Lori Ellis, the panelists included Firas Abdessalem of Sanofi, Christopher Hart of Foley Hoag, Ricardo Gaminha Pacheco of InSilico Medicine, and Artemy Shumskiy of Latvian VC company LongeVC. Together they discussed how the EU’s AI Act is likely to impact innovation, funding, and partnerships in the life sciences.

    Nov 12, 2024

  • Ensuring Study Participant Adherence: Strategies for Successful Remote Data Collection in Clinical Trials Using Wearable Technologies

    Clinical Research News | Ensuring clinical trial participants adhere to study protocols is essential for reliable clinical trial results. If participants aren't consistent with their participation, the data collected won't accurately reflect the effectiveness of a treatment or therapy. Poor adherence can slow down or even derail clinical breakthroughs.

    Nov 8, 2024